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Summary
Perturbation of endoplasmic reticulum (ER) homeostasis impairs insulin biosynthesis, b cell survival, and glucose homeo-
stasis.We show that amurinemodel of diabetes is associatedwith the development of ER stress inb cells and that treatment
with the GLP-1R agonist exendin-4 significantly reduced biochemical markers of islet ER stress in vivo. Exendin-4 attenu-
ated translational downregulation of insulin and improved cell survival in purified rat b cells and in INS-1 cells following in-
duction of ER stress in vitro. GLP-1R agonists significantly potentiated the induction of ATF-4 by ER stress and accelerated
recovery from ER stress-mediated translational repression in INS-1 b cells in a PKA-dependent manner. The effects of
exendin-4 on the induction of ATF-4 were mediated via enhancement of ER stress-stimulated ATF-4 translation. Moreover,
exendin-4 reduced ER stress-associated b cell death in a PKA-dependent manner. These findings demonstrate that GLP-1R
signaling directly modulates the ER stress response leading to promotion of b cell adaptation and survival.Introduction
Glucose homeostasis is preserved through interdependent
maintenance of insulin action in peripheral tissues such as liver
andmuscle, together with basal and nutrient-dependent regula-
tionof insulin secretion from isletbcells. Impairment of insulin ac-
tion in peripheral tissues is viewed as an early defect contributing
to the development of diabetes in susceptible individuals (Kim-
merling et al., 1976; Rothman et al., 1995). Although the mecha-
nisms responsible for the development of insulin resistance re-
main unclear, genetic defects, inflammation, elevated levels of
free fatty acids, and impairment of mitochondrial function have
been invoked as important determinants of insulin sensitivity in
populations at risk for the development of diabetes (Lowell and
Shulman, 2005; Perseghin et al., 2003). Intriguingly, many of
themolecular andmetabolic defects contributing to thedevelop-
ment of insulin resistance are also implicated in thepathogenesis
of impairedbcell functionand lossofbcellmass that accompany
the loss of glucose control in diabetic subjects (Rhodes, 2005).
The requirement for enhanced production and secretion of in-
sulin in the setting of increasing insulin resistance necessitates
that the diabetic b cell adapt by upregulating insulin biosynthesis
while simultaneously preserving b cell survival. Paradoxically,
inadequate control of glycemia has been associatedwith activa-
tion of both oxidative and endoplasmic reticulum (ER) stress sig-
naling pathways (Kaneto et al., 2005; Kharroubi et al., 2004; Lay-
butt et al., 2002; Robertson, 2004; Wang et al., 2005), leading to
reduced insulin secretion and enhanced susceptibility to b cell
death. Furthermore, insulin secretagogues of the sulphonylurea
class robustly increase insulin exocytosis, but not insulin biosyn-
thesis (Garcia et al., 1976), and may be associated with induc-
tion of b cell apoptosis in vitro (Efanova et al., 1998; Maedler
et al., 2005).CELL METABOLISM 4, 391–406, NOVEMBER 2006 ª2006 ELSEVIER INSeveral independent lines of genetic evidence implicate a role
for ER homeostasis in b cell function and survival. For example,
mutations in the insulin gene resulting in misfolding of insulin,
and both enlargement and dysfunction of the ER, lead to re-
duced b cell insulin secretion and diabetes (Wang et al.,
1999a). Similarly, mutations in key components of the ER stress
response also lead to loss of b cell mass and diabetes in rodents
(Harding et al., 2001; Scheuner et al., 2001). Furthermore, com-
ponents of the ER stress pathway are also essential for b cell
function in human subjects, as exemplified by the development
of b cell loss and diabetes in individuals harboring mutations in
the pancreatic ER kinase (PERK) (Delepine et al., 2000) and in
the WFS1 gene (Fonseca et al., 2005; Inoue et al., 1998).
The signaling pathways engaged following ER stress are
complex and involve three different arms of the unfolded protein
response (UPR) (Ron, 2002; Wek et al., 2006; Wu and Kaufman,
2006) whose activation relies on the ER stress luminal sensors
ATF6, IRE1, and PERK. Activated PERK phosphorylates the
translation initiation factor eIF2a, which transiently attenuates
global protein synthesis, reducing the load on the ER. A second
arm of the UPR, mediated by activated IRE1, splices XBP-1
mRNA leading to generation of an active transcription factor. Fi-
nally, intramembrane cleavage releases the cytosolic domain of
ATF6 that also functions as a transcription factor. Both XBP-1
and ATF6 are involved in the activation of genes encoding mo-
lecular chaperones and proteins involved in ER-associated deg-
radation and are therefore important to enhance ER function. ER
stress-mediated eIF2a phosphorylation and ensuing repression
of general translation allow the dysfunctional ER a window of
opportunity to recover from cellular stress. However, eIF2a
phosphorylation also leads to enhanced translation of ATF-4
(Harding et al., 2000a; Lu et al., 2004; Vattem and Wek, 2004),
which in turn upregulates the expression of key genes importantC. DOI 10.1016/j.cmet.2006.10.001 391
A R T I C L Efor the recovery from ER stress. Translational recovery in ER-
stressed cells is mediated by GADD34, a regulatory protein
that recruits and activates the catalytic subunit of type 1 protein
phosphatase (PP1c), targeting it to the ER to promote eIF2a de-
phosphorylation (Ma and Hendershot, 2003; Novoa et al., 2001;
Novoa et al., 2003).
A growing body of evidence suggests that incretin hormones,
exemplified by glucagon-like peptide-1 (GLP-1), not only in-
crease insulin secretion but also act directly on the b cell to up-
regulate insulin biosynthesis, while enhancing resistance to
b cell death (Buteau et al., 2004; Farilla et al., 2003; Jhala
et al., 2003; Li et al., 2003; Perfetti et al., 2000; Wang et al.,
2004). To explore potential mechanisms coupling GLP-1 recep-
tor (GLP-1R) activation to enhanced insulin translation and the
prevention of b cell apoptosis, we searched for a connection be-
tween G protein-coupled receptor (GPCR)-activated signaling
pathways linking GLP-1 action to modulation of ER stress. We
show here that engagement of the GLP-1R directly regulates
the PERK arm of the UPR, providing a mechanism for b cell
adaptation to metabolic and cellular stress.
Results
GLP-1R agonists have previously been shown to either prevent
or ameliorate experimental diabetes and preserve b cell mass in
multiple preclinical models (Drucker, 2006), including the db/db
mouse (Kim et al., 2003; Wang and Brubaker, 2002). Accord-
ingly, we examined glucose control, islet histology, and the ex-
pression of markers important for the response to ER stress in
diabetic mice treated with vehicle alone or with exendin-4, a po-
tent GLP-1R agonist. The transcription factor CHOP subserves
a number of important cellular functions and has also been im-
plicated as a critical component of the ER stress response (Oya-
domari and Mori, 2004). We detected a progressive increase in
CHOP-positive nuclei following serial analysis of islets from db/
db mice in the absence of exendin-4 treatment at various ages
(data not shown). Furthermore, treatment of db/db mice with
exendin-4 for 3 weeks produced a significant decrease in CHOP
expression in islet b cells (Figure 1A), together with a reduction
in levels of blood glucose (Figure 1B), and a significant increase
in levels of mRNA transcripts for insulin and IRS-2 (Figure 1C).
Furthermore, exendin-4 markedly reduced the pancreatic levels
of spliced XBP-1 (sXBP-1) RNA transcripts in the same experi-
ment (Figure 1D). Taken together, these data illustrate that the
GLP-1R agonist exendin-4 reduces pancreatic expression of
CHOP and sXBP-1, molecular mediators involved in the cellular
response to ER stress.
To ascertain whether GLP-1R activation directly regulates the
ER stress response in b cells, we treated cultured purified rat
b cells with thapsigargin, a pharmacological inducer of ER
stress, for 12 hr in the presence or absence of exendin-4 or for-
skolin. Exendin-4 and forskolin significantly suppressed thapsi-
gargin-induced b cell apoptosis in isolated rat b cells (Figure 1E
and data not shown). Furthermore, the cytoprotective actions of
exendin-4 were completely abrogated by H89, a protein kinase
A inhibitor (Figure 1E). Similarly, thapsigargin markedly sup-
pressed insulin synthesis in short-term cultures of isolated rat
b cells (Table 1), whereas exendin-4 and forskolin (Table 1) up-
regulated insulin synthesis in thapsigargin-treated rat b cells in
vitro. Hence, these findings illustrate that GLP-1R activation at-
tenuates the expression of CHOP and sXBP-1 in b cells of dia-392betic mice and directly engages pathways modulating ER
stress-associated translational repression and cell death in
isolated nontransformed b cells.
To determine whether GLP-1R signaling also regulated com-
ponents of the UPR in islet cell lines, we exposed rat insulinoma
INS-1(832/13) cells to pharmacological inducers of ER stress
in the presence or absence of exendin-4. Development of the
ER stress response was assessed by measuring the levels of
ATF-4 and sXBP-1, reporters of activation of the PERK and
IRE1 arms, respectively, of the UPR (Harding et al., 2002;
Kaufman et al., 2002; Shen et al., 2004). Both thapsigargin
and tunicamycin upregulated ATF-4 and sXBP-1 protein levels
in INS-1(832/13) cells, albeit with different kinetics (Figure 2A).
Furthermore, exendin-4 markedly enhanced the magnitude of
ATF-4 and sXBP-1 induction in the presence of either thapsigar-
gin or tunicamycin (Figure 2A). Additional experiments dem-
onstrated that the effects of exendin-4 on sXBP-1 in ER-stressed
INS-1 cells are associated with increased expression of
chaperone-encoding genes such as DnaJb9 (see Figure S1 in
the Supplemental data available with this article online). The
upregulation of ATF-4 and sXBP-1 following ER stress was
also potentiated by exendin-4 in the parental INS-1 cell line
(data not shown) and in the mouse insulinoma cell line MIN6
(Figure 2B). These results demonstrate that activation of
GLP-1R signaling modifies the UPR in b cell lines via direct
upregulation of ATF-4 and sXBP-1 expression.
As ATF-4 is translationally induced during ER stress in re-
sponse to PERK-mediated eIF2a phosphorylation (Harding
et al., 2000a), we examined whether exendin-4 regulates ATF-
4 induction via modulation of eIF2a phosphorylation. The exen-
din-4-mediated overinduction of ATF-4 expression was associ-
ated with decreased levels of phospho-Ser51 eIF2a compared
to the levels detected in cells treatedwith thapsigargin or tunica-
mycin alone (Figure 2C). Moreover, exendin-4 increased the
levels of CHOPmRNA transcripts (Figure S2) and CHOP protein
(Figure 2C), a target of ATF-4 transcriptional regulation (Harding
et al., 2000a; Jiang et al., 2004; Ma et al., 2002), following incu-
bation of INS-1 cells with either thapsigargin or tunicamycin.
These observations demonstrate that exendin-4 regulates not
only ATF-4 but also enhances the expression of downstream
targets of ATF-4. Furthermore, the effects of exendin-4 on
eIF2a phosphorylation and both ATF-4 and CHOP induction
were reproduced with native GLP-1 (Figure S3A), the endoge-
nous ligand for the mammalian GLP-1R, with the GIP receptor
agonist [D-Ala2]GIP (Figure S3B) and with forskolin (Figure 2C
and Figure S3A), implicating cAMP as a potential intermediary
linking incretin hormone receptor activation to the PERK arm
of the ER stress response.
Activation of the GLP-1R in b cells engages cAMP/PKA, Erk1/
2MAP kinase, and PI-3 kinase/Akt signaling (Buteau et al., 1999,
2001; Drucker, 2006; Drucker et al., 1987; Wang and Brubaker,
2002). To identify mechanisms coupling GLP-1R activation to
the modulation of the ER stress response, we used kinase inhib-
itors to selectively inactivate intracellular signaling pathways in
the presence or absence of exendin-4. The effectiveness of
the different inhibitors to block the activity of their corresponding
target kinases in INS-1 cells is illustrated in Figure S6. Incubation
of INS-1 cells with either H89, U0126, or LY294002 alone did not
interfere with the activation of the PERK arm of the UPR in re-
sponse to ER stress (Figure 2D). However, the PKA inhibitor
H89 prevented the potentiation of ATF-4 and CHOP inductionCELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressFigure 1. Exendin-4 reduces the expression of
markers of ER stress in b cells from db/db mice
and enhances survival of purified rat b cells sub-
jected to ER stress
db/db mice (4 weeks old) were given twice-daily i.p
injections of PBS (vehicle) or exendin-4 (Ex-4) for 3
weeks. Body weights at the end of the 3-week treat-
ment period were 30.9 6 0.8 g versus 28.6 6 0.7 g
for PBS versus Ex-4-treated mice, p < 0.05. Blood
glucose levels were determined and pancreata
were obtained for immunohistochemical and RNA
analyses.
A) Photomicrographs of representative islet CHOP
staining (arrows point to CHOP-positive nuclei) in
vehicle- and exendin-4-treated mice. Islet perimeter
is marked by a dashed line. Magnification, 4003. The
number of CHOP-positive b cells normalized per
b cell area was quantified as described in Experi-
mental Procedures. Data are means 6 SD (n = 6
mice per group). Analysis of serial adjacent sections
stained with antisera to insulin and CHOP demon-
strated that the majority of CHOP-positive islet cells
corresponded to b cells; 80.3% 6 14.4% (saline-
treated mice) and 88.4% 6 12% (exendin-4-treated
mice). CHOP-positive nuclei were rarely seen in exo-
crine pancreas.
B) Blood glucose levels in vehicle- and exendin-
4-treated mice immediately prior to sacrifice. Data
are means 6 SD (n = 9 mice per group).
C) Pancreatic insulin and IRS-2 mRNA levels as-
sessed by real-time quantitative RT-PCR in vehicle-
and exendin-4-treated mice. Data are means 6 SD
(n = 4 mice per group) and are normalized to levels
of glucokinase mRNA transcripts in the same RNA
preparations.
D) PCR products amplified from unspliced (uXBP-1)
and spliced (sXBP-1) pancreatic XBP-1 mRNA from
four vehicle- and four exendin-4-treated mice. The
percentage of sXBP-1 to total XBP-1 determined
by densitometry is illustrated. Data are means 6
SD (n = 4 mice per group). For (A)–(D), *p < 0.05,
**p < 0.01, and ***p < 0.001 for Ex-4 versus vehicle.
E) Purified rat b cells were exposed to either vehicle
alone or H89 during a 12 hr treatment with vehicle
(Veh) or 0.5 mM thapsigargin (Tg) in the absence or
presence of 10 nM exendin-4 (Ex-4). The apoptotic
index was calculated as described in Experimental
Procedures. Data represent means 6 SE of four in-
dependent experiments. ***p < 0.001 for Tg+Ex-4
versus Tg alone.and the attenuation of eIF2a phosphorylation by exendin-4 or
forskolin in thapsigargin-treated cells (Figure 2D). In contrast,
the MEK1/2 inhibitor U0126 or the PI-3 kinase inhibitor
LY294002 had no effect on exendin-4-mediated changes in
ATF-4, CHOP, or eIF2a phosphorylation (Figure 2D). Identical
results were obtained using PD98059 and wortmannin, different
inhibitors for MEK1/2 and PI-3 kinase, respectively (data not
shown). These observations strongly suggest that cAMP and
PKA are the intracellular mediators involved in the modulation
of the PERK arm of the UPR by GLP-1R agonists.
To explore the mechanisms responsible for the paradoxical
relationship between reduced eIF2a phosphorylation yet in-
creased ATF-4 levels in INS-1 cells undergoing ER stress inCELL METABOLISM : NOVEMBER 2006the presence of GLP-1R agonists or forskolin, we performed
a detailed analysis of the temporal relationship between ATF-4
induction and eIF2a phosphorylation. Levels of ATF-4 were in-
creased by 1 hr of thapsigargin treatment with maximal induc-
tion occurring following 4–6 hr of exposure (Figure 3A; see
also Figure 2A and Figure 4C). Forskolin did not modify the tem-
poral profile of ATF-4 accumulation but significantly increased
the magnitude of ATF-4 induction. Similarly, CHOP was also in-
duced by thapsigargin and further upregulated by forskolin yet
with delayed kinetics compared to ATF-4 (Figure 3A), consistent
with ATF-4’s role as an upstream activator of the CHOP pro-
moter (Harding et al., 2000a; Jiang et al., 2004; Ma et al.,
2002). Phosphorylation of eIF2a increased rapidly in393
A R T I C L Ethapsigargin-treated INS-1 cells and was sustained for 4 hr
(Figure 3B). Coincubation of INS-1 cells with thapsigargin and
either exendin-4 or forskolin did not affect the initial phase of
eIF2a phosphorylation kinetics; however, exendin-4 or forskolin
reduced the levels of eIF2a phosphorylation from 2 to 4 hr after
thapsigargin exposure (Figure 3B). Hence, overinduction of
ATF-4 expression by exendin-4 and/or forskolin during ER
stress is an early event relative to the subsequent decrease in
eIF2a phosphorylation, raising the possibility that activation of
GLP-1R signaling in b cells undergoing ER stress results in mod-
ulation of ATF-4 induction and eIF2a phosphorylation by differ-
ent mechanisms.
PERK is the primary eIF2a kinase induced by ER stress (Har-
ding et al., 1999; Jiang et al., 2004). To ascertain its contribution
to the decrease in phospho-eIF2a in ER-stressed b cells treated
with GLP-1R agonists, we assessed the activation state of
PERK by following the characteristic shift in mobility of the phos-
phorylated active form of the protein by SDS-PAGE (Harding
et al., 1999, 2000a). PERK phosphorylation was detectable in
INS-1 cells as early as 20 min following thapsigargin treatment,
was maintained for at least 4 hr, and was not prevented but was
actually accentuated by coincubation with exendin-4 or forsko-
lin (Figure 3C). As a reduction in eIF2a phosphorylation was
prominent in exendin-4-treated cells (Figure 3B) despite persis-
tent activation of the upstream kinase PERK (Figure 3C), these
findings demonstrate that exendin-4 exerts its effects on
eIF2a phosphorylation downstream of PERK.
To determine the functional significance of the changes in
phospho-eIF2a levels in ER-stressed b cells treated with GLP-
1R agonists, wemeasured the incorporation of radiolabeled leu-
cine into newly synthesized proteins. Phosphorylation of the
a subunit of eIF2 attenuates eIF2-GTP-tRNAi
met ternary com-
plex formation, thereby reducing global translation initiation
and polypeptide biosynthesis, which is followed by a phase of
eIF2a dephosphorylation and translational recovery (Harding
et al., 2002; Kaufman et al., 2002). Thapsigargin produced
a rapid and profound repression of translation in INS-1 cells,
followed by a slow and quantitatively modest recovery after
several hours (Figure 4A). Exendin-4 markedly enhanced the
magnitude of translational recovery following thapsigargin ex-
Table 1. Effects of exendin-4 and forskolin on thapsigargin-induced suppression




Tg Ex-4/Fk 0 mM glucose 10 mM glucose
Experiment 1 (n = 4)
– – 0.20 6 0.06 3.00 6 0.27
– Ex-4 0.36 6 0.11 3.23 6 0.34
+ – 0.04 6 0.01 0.90 6 0.09
+ Ex-4 0.11 6 0.02a 1.21 6 0.07b
Experiment 2 (n = 6)
– – 0.27 6 0.04 3.30 6 0.37
– Fk 1.24 6 0.23a 4.12 6 0.51
+ – 0.07 6 0.02 1.22 6 0.16
+ Fk 0.42 6 0.08a 2.11 6 0.30a
Rat b cells were cultured for 8 hr with or without thapsigargin (Tg, 0.5 mM) in the
presence of exendin-4 (Ex-4, 10 nM) or forskolin (Fk, 20 mM). Data represent
mean 6 SE of (n) independent experiments.
a p<0.01, b p<0.05 versus control cultures in the absence of Ex-4 or Fk.394posure (Figure 4A). The effect of exendin-4 on recovery from
ER stress-induced translational repression was mimicked by
forskolin (Figures 4A and 4B) and abrogated by preincubation
with H89 (Figure 4B). Although H89 attenuated global protein
synthesis on its own, this effect did not seem to result from cy-
totoxicity. Glucose-stimulated protein synthesis is brought
about mainly by dephosphorylation of eIF2a in b cells (Gomez
et al., 2004) andwas preserved following exposure of INS-1 cells
to H89 either in the absence or presence of concomitant ER
stress (data not shown). These results indicate that exendin-4
acting downstream of PERK attenuates phospho-eIF2a levels,
thus promoting a faster resumption of protein synthesis during
ER stress.
Dephosphorylation of eIF2a is catalyzed by the ER stress-
inducible gene Gadd34. Gadd34 encodes a regulatory protein
that recruits and activates the catalytic subunit of PP1c, target-
ing it to the ER to promote eIF2a dephosphorylation and trans-
lational recovery from the early phase of translational repression
during the ER stress response (Novoa et al., 2001, 2003). ATF-4
(Jiang et al., 2004; Ma and Hendershot, 2003) and CHOP (Mar-
ciniak et al., 2004) directly activate Gadd34, delineating a neg-
ative feedback loop that controls protein translation during
ER stress. To ascertain whether GLP-1R signaling engages
GADD34, resulting in reduced phospho-eIF2a, we measured
the levels of PP1c-associated GADD34, an indicator of the
abundance of the ER stress-induced eIF2a holophosphatase
complex. PP1c-associated GADD34 was isolated by microcys-
tin affinity chromatography, which efficiently purifies PP1c ow-
ing to its high-capacity binding to this phosphatase (Campos
et al., 1996). The GADD34-PP1c complex, but not PP1c alone,
was expressed at low levels in unstressed cells. Thapsigargin in-
duced PP1c-associated GADD34 expression, whichwas further
augmented in cells coincubated with exendin-4 or forskolin
(Figure 4C). Furthermore, the abundance of the GADD34-PP1c
complex correlated with the eIF2a dephosphorylation kinetics
following ER stress in the presence of exendin-4 or forskolin
(Figure 4C). Both the overinduction of GADD34 and the associ-
ated reduction in levels of phospho-eIF2a in thapsigargin-
treated INS-1 cells coincubated with either exendin-4 or
forskolin was prevented by H89 (Figure 4D). Exendin-4 also
upregulated the expression of GADD34 mRNA transcripts
following induction of ER stress in INS-1 cells treated with tuni-
camycin (Figure S4). These results indicate that exendin-4, in
a cAMP- and PKA-dependent manner, potentiates the induction
of the eIF2a phosphatase complex during the ER stress re-
sponse, resulting in attenuation of levels of phospho-eIF2a
and a faster recovery from translational repression.
The previous results highlight the functional significance of the
pathways regulated by exendin-4 that contribute to relief of ER
stress-mediated translational repression in INS-1 cells. To de-
termine how GLP-1 receptor agonists promote induction of
ATF-4, we assessed the regulation of ATF-4 mRNA during ER
stress. Levels of ATF-4 transcripts were increased following
treatment of INS-1 cells with thapsigargin alone; however,
they were not further upregulated following coincubation with
exendin-4 or forskolin (Figure 5A), suggesting a posttranscrip-
tional mechanism for the actions of exendin-4 on ATF-4 induc-
tion during ER stress. This conclusion was further supported
by the observation that treatment with actinomycin D did not ab-
rogate the further induction of ATF-4 protein by exendin-4 or for-
skolin following incubation of INS-1 cells with thapsigargin forCELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressFigure 2. Exendin-4 regulates both the PERK and
the IRE1/XBP-1 arms of the UPR in rodent insuli-
noma cell lines
Rat INS-1 (A, C, and D) or mouse MIN6 (B) insuli-
noma cells were treated with vehicle alone, thapsi-
gargin (Tg), or tunicamycin (Tm) in the absence or
presence of 50 nM exendin-4 (Ex-4 or E) or 20 mM
forskolin (Fk or F) for the indicated periods of time
(A and B) or for 4 hr (C and D). In (D), cultures were
exposed to vehicle alone or to either H89, U0126,
or LY294002 (LY) for 20 min prior to and during the
4 hr treatment with thapsigargin in the absence or
presence of exendin-4 or forskolin. Total cell extracts
were analyzed by immunoblotting for ATF-4, XBP-1,
phospho-eIF2a Ser51 (P[Ser51]-eIF2a), and CHOP
as indicated. The signal shown in the XBP-1 immu-
noblot corresponds to thew54 kDa protein encoded
by the sXBP-1 mRNA (sXBP-1). Anti-Hsp90 antibody
was used to monitor loading and transfer conditions.
Results shown in (A), (B), and (C) are representative
of four, three, and two independent experiments,
respectively. In (D), results are representative of
four (H89) and two (U0126 and LY294002) similar
experiments.1 hr (Figure S5A). To determine whether the effect of exendin-4
on ER stress-triggered ATF-4 induction was mediated by in-
creased protein stability, we examined the rate of ATF-4 decay
after translational inhibition with cycloheximide. In contrast to
the relative stability of CHOP and Hsp90, levels of ATF-4 protein
decayed rapidly following cycloheximide treatment (Figure 5B),
consistent with the previously reported instability of ATF-4 (Blais
et al., 2004; Lassot et al., 2001). The t1/2 of ATF-4 protein wasCELL METABOLISM : NOVEMBER 2006w20 min in cells exposed to thapsigargin alone and did not
change following coincubation with exendin-4 or forskolin.
Hence, ATF-4 protein stabilization does not contribute to the
GLP-1R-dependent potentiation of ATF-4 protein accumulation
during ER stress.
Previous studies have implicated the 50UTR of the ATF-4
mRNA in its translational regulation by ER stress-induced
eIF2a phosphorylation (Harding et al., 2000a; Lu et al., 2004;395
A R T I C L EFigure 3. Exendin-4 affects eIF2a phosphorylation in ER-stressed INS-1 cells downstream of PERK
Cells were exposed to vehicle alone or thapsigargin (Tg) in the absence or presence of exendin-4 (Ex-4) or forskolin (Fk or F) for the indicated periods of time. Total cell
extracts were then analyzed by immunoblotting for ATF-4 and CHOP (A), P(Ser51)-eIF2a (B), PERK (C), and Hsp90 (loading control). Plotted in (A) and (B) are the intensity of
the ATF-4 and CHOP signals and of the P(Ser51)-eIF2a signal, respectively, quantified by densitometry, corrected by the intensity of the Hsp90 signal, and expressed
relative to the values at time zero. Data in (A) are means from two independent experiments. Data in (B) are the means6 SEM from three to four independent experiments.
Coefficients of variation were%15% for the time points in the kinetics whose SEM has been omitted for the purpose of clarity. (C) depicts the active phosphorylated form of
PERK (P-PERK) with reducedmobility compared to its inactive underphosphorylated form (PERK). Blots shown in (C) are representative of three independent experiments.396 CELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressVattem and Wek, 2004). Therefore, we examined the activity of
a transfected plasmid construct carrying the murine ATF-4
mRNA 50UTR and initiation codon fused to the luciferase re-
porter gene (TK-ATF4UTR-Luc) (Harding et al., 2000a). Reporter
gene activity was unaffected by incubation of INS-1 cells with ei-
ther exendin-4 or forskolin alone (Figure 5C). However, lucifer-
ase expression was increased 4- to 5-fold following exposure
of the cells to thapsigargin for 8 hr, and both exendin-4 and for-
skolin further enhanced luciferase activity byw8-fold in thapsi-
gargin-treated cells (Figure 5C). Because levels of ATF-4-lucifer-
ase mRNA transcripts did not change regardless of the
treatment condition (Figure 5C), these results support a transla-
tional mechanism for the overinduction of ATF-4 protein expres-
sion by exendin-4 during ER stress.
To independently address the same issue using a different ex-
perimental technique, we measured the rate of ATF-4 protein
synthesis in INS-1 cells by pulse labeling with [35S]Met/Cys
and immunoprecipitation with an ATF-4-specific antibody. As
shown in Figure 5D, incorporation of [35S]Met/Cys into nascent
ATF-4 followed the same pattern as the changes in levels of
ATF-4 protein assessed by western blotting. Incorporation of
[35S]Met/Cys into ATF-4 was comparatively low in unstressed
vehicle-treated cells or in cells treated with exendin-4 alone. In
contrast, INS-1 cells exposed to a 1 hr thapsigargin challenge
exhibited a 2- to 4-fold increase in newly synthesized ATF-4
and a further increase in newly synthesized ATF-4 (43.0% 6
8.3%, n = 4 independent experiments) was observed in cells
treated with both thapsigargin and exendin-4 (Figure 5D). Gen-
eral translation rate, as assessed by the incorporation of
[35S]Met/Cys into proteins, was inhibited to the same extent fol-
lowing thapsigargin treatment for 1 hr either in the absence or
presence of exendin-4, in agreement with the parallel induction
of similar eIF2a phosphorylation levels under both conditions
(Figure 5D).
The UPR in mammalian cells promotes adaptation to ER
stress imposed by physiological requirements for upregulation
of protein synthesis and secretion, leading to maintenance of
ER homeostasis and cell survival. Although persistent activation
of the UPR may lead to apoptosis, thereby eliminating cells with
irreparable damage caused by severe ER stress (Harding et al.,
2002; Shen et al., 2004), we observed that exendin-4 improved
cell survival following induction of ER stress in primary cultures
of rat b cells (Figure 1E). To determine the mechanisms linking
GLP-1R activation with enhanced cell survival in the presence
of ER stress, INS-1 cells were subjected to a thapsigargin chal-
lenge for 8 hr in the presence or absence of exendin-4 or forsko-
lin, followed by recovery in regular growth media. In this exper-
iment, outgrowth of cell colonies after thapsigargin treatment
reflects cell survival following induction of ER stress. Consistent
with the data depicted in Figure 1E, treatment of INS-1 cells with
either exendin-4 or forskolin for 8 hr produced more numerous
and larger cell colonies after a concomitant thapsigargin pulse
(Figure 6A). GLP-1, exendin-4, and forskolin independently en-
hanced INS-1 cell colony formation in similar experiments
(Figure 6B). As GLP-1R agonists attenuate apoptosis and pro-
mote proliferation of pancreatic b cells (Drucker, 2003), we ex-
amined the impact of exendin-4 on b cell proliferation and sur-
vival in the setting of ER stress. Within 24 hr of the transient
thapsigargin pulse, INS-1 cells demonstrated signs of apopto-
sis, including membrane blebbing, cell detachment, chromatin
condensation, and nuclear disintegration and cell fragmentationCELL METABOLISM : NOVEMBER 2006into apoptotic bodies (data not shown). The manifestation of
these changes preceded a marked reduction in the number
of viable cells during the next 48 hr followed by resumption of
cell growth (Figure 6C). Coincubation of INS-1 cells with exen-
din-4 or forskolin during the initial 8 hr exposure to thapsigargin
markedly reduced the subsequent loss of viable cells within the
first 3 days. However, cell growth resumed and appeared com-
parable in all three groups at later time points (Figure 6C). Fur-
thermore, exposure to exendin-4 or forskolin alone in the ab-
sence of thapsigargin for 8 hr did not affect subsequent INS-1
cell growth (Figure 6D). Consequently, the enhanced cell colony
outgrowth observed in INS-1 cell cultures exposed to exendin-4
or forskolin during the thapsigargin pulse is most consistent with
inhibitory actions of exendin-4 and forskolin on thapsigargin-
induced cell death. Similar results were obtained in identical
experiments performed using MIN6 cells (data not shown). Fur-
thermore, stimulation of endogenous insulin release by tolbuta-
mide or glybenclamide, or addition of exogenous insulin, did not
affect survival in ER-stressed INS-1 cells. Moreover, inhibition of
insulin exocytosis by diazoxide did not abrogate the prosurvival
effect of exendin-4 in INS-1 cells undergoing ER stress (data
not shown). These results suggest that insulin released following
exendin-4 treatment of INS-1 cells does not play a role in the
ability of GLP-1R agonists to inhibit ER stress-mediated cell
death.
The role of different intracellular signaling pathways inmediat-
ing the enhanced survival of exendin-4-treated INS-1 cells fol-
lowing ER stress-induced cell death was assessed using kinase
inhibitors. Inhibition of MEK1/2 kinase by PD98059 or U0126 did
not attenuate exendin-4 or forskolin-mediated enhancement of
INS-1 cell colony outgrowth after a thapsigargin challenge (Fig-
ure 6E). Similarly, the PI-3 kinase inhibitors wortmannin or
LY294002 failed to diminish the prosurvival actions of exen-
din-4 or forskolin in the same experiments (Figure 6F). These re-
sults indicate that both MEK1/2 kinase and PI-3 kinase are dis-
pensable for the inhibitory effects of exendin-4 and forskolin on
ER stress-induced INS-1 cell death. In contrast, H89 signifi-
cantly attenuated the actions of exendin-4 and forskolin on
enhancement of INS-1 cell colony growth (Figure 6G). These
observations strongly suggest that cAMP and PKA are key
intracellular mediators coupling GLP-1R activation to modula-
tion of ER stress-induced cell death in INS-1 cells.
Discussion
The observation that human diabetic subjects exhibit an early
defect in glucose-stimulated insulin secretion (Bagdade et al.,
1967), together with findings from autopsy studies demonstrat-
ing reduced b cell mass in diabetic subjects (Butler et al., 2003),
have focused efforts on development of intervention strategies
that improve b cell function and prevent b cell death. Hence,
there is active interest in determining whether newer drugs
such as the insulin sensitizing agents will produce sustained im-
provements in b cell function and thereby alter the natural history
of type 2 diabetes (Buchanan et al., 2002; Ovalle and Bell, 2004;
Rhodes, 2005). Increasing experimental evidence implicates
a role for ER stress in the development of progressive reductions
in insulin secretion associated with b cell failure and apoptotic
b cell death (Scheuner et al., 2005; Wang et al., 2005; Wang
et al., 1999a). GLP-1R agonists such as exendin-4 maintain in-
sulin biosynthesis and secretion while expanding islet mass397
A R T I C L EFigure 4. Exendin-4 accelerates recovery from ER stress-induced translational repression in INS-1 by potentiating the induction of the GADD34-PP1c eIF2a phosphatase
complex
Cultures were treated with vehicle alone (Veh or V) or 0.5 mM thapsigargin (Tg or T) in the absence or presence of 50 nM exendin-4 (Ex-4 or E) or 20 mM forskolin (Fk or F) for
the indicated periods of time (A and C) or were exposed to vehicle alone or H89 for 20 min prior to and during a 4.5 hr (B) or 4 hr (D) treatment with thapsigargin in the398 CELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressthrough direct effects on activation of b cell proliferation and in-
hibition of b cell death (Drucker, 2003; Kim et al., 2003; Li et al.,
2003; Wang et al., 2004; Xu et al., 1999). GLP-1R agonists also
lower blood glucose via multiple actions independent of the islet
b cell, including reduction in gastric emptying, glucagon secre-
tion and body weight. Hence, experiments demonstrating GLP-
1R-dependent improvement in b cell function in rodents may
reflect both indirect and direct aspects of GLP-1R action that
converge on reduction of blood glucose and lipotoxicity.
Although reduction of ER stress in peripheral insulin-sensitive
tissues may also be associated with the amelioration of experi-
mental diabetes (Ozcan et al., 2004), we now demonstrate that
GLP-1R signaling pathways are directly coupled to modulation
of the UPR and improved survival of ER-stressed b cells.
Currently available insulin secretagogues such as the sulfo-
nylureas or the glitinides promote insulin exocytosis without act-
ing more proximally to enhance insulin biosynthesis (Garcia
et al., 1976; Schatz et al., 1975). In contrast, GLP-1R activation
leads to induction of insulin gene transcription (Drucker et al.,
1987) and increased pancreatic insulin biosynthesis (Hosokawa
et al., 1996), leading to replenishment of b cell insulin content.
GLP-1 is thought to increase insulin biosynthesis through induc-
tion of Pdx-1 transcription, leading to enhanced insulin gene ex-
pression (Wang et al., 1999b, 2001). Our data extend the con-
cept of GLP-1 action in the b cell to control of translational
repression downstream of PERK by attenuation of levels of
phospho-eIF2a, thereby promoting a faster resumption of pro-
tein synthesis during ER stress.
Our results are consistent with a sequence of events (Fig-
ure S7) whereby activation of the GLP-1R magnifies the ER
stress-mediated induction of the transcriptional activator ATF-
4 in a cAMP- and PKA-dependent manner. While we cannot
exclude a role for signaling molecules such as EPAC as down-
stream mediators of the GLP-1R response (Holz, 2004), the ob-
servation that H89 abolished a number of actions of exendin-4 in
the setting of ER stress implicates a major role for PKA in cou-
pling GLP-1R actions to modulation of the UPR in INS-1 cells.
We provide evidence strongly suggesting that stimulation of
ATF-4 translation is the target for the early modulation of ER
stress-mediated ATF-4 induction by GLP-1R activation in INS-
1 cells, yet additional experiments will be required to further de-
fine whether this regulation occurs at the level of translation ini-
tiation and/or ribosomal transit time. The overinduction of ATF-4
early during the ER stress response would promote the ensuing
enhanced upregulation of the downstream transcriptional tar-
gets CHOP and GADD34. ATF-4- and CHOP-mediated overin-
duction of GADD34, by significantly increasing the levels of
the eIF2a phosphatase complex, would initiate the subsequent
later phase of exendin-4-dependent attenuation of phospho-
eIF2a levels, resulting in enhanced translational recovery. The
higher protein synthesis rate during this later phase would fur-
ther contribute to the sustained upregulation of ATF-4,
GADD34, and CHOP but would also impact indirectly on theCELL METABOLISM : NOVEMBER 2006IRE1/XBP-1 arm of the UPR by facilitating the induction of the
transcriptional activator sXBP-1.
We have shown that modulation of the activity of the PERK
arm of the UPR by exendin-4 in b cells undergoing ER stress fa-
cilitates the shift from translational repression to the translational
recovery phase. This shift is known to be required to implement
the ER stress-induced gene expression program that transiently
allowsmaintenance of ER homeostasis, thus promoting cell sur-
vival (Harding et al., 2000b). The same UPR can also contribute
to cell death if activated persistently by sustained ER stress. Our
findings explain the paradox of howGLP-1R signaling enhances
both insulin biosynthesis and secretion while simultaneously
reducing cell death in response to ER stress.
GLP-1R agonists have been shown to attenuate b cell death
using rodent models of b cell apoptosis in vivo (Farilla et al.,
2002; Li et al., 2003; Wang and Brubaker, 2002) and following
a diverse number of experimental insults including exposure to
cytotoxic agents, free fatty acids, and increased glucose in vitro
(Buteau et al., 2004; Farilla et al., 2003; Wang et al., 2004). Col-
lectively, activation of GLP-1R signaling increases levels of
cAMP, Akt, and IRS-2 (Jhala et al., 2003), leading to reduced ex-
pression and activation of effector caspases. The data shown
here extend the spectrum of antiapoptotic GLP-1 actions to
ER stress-induced cell death, linking GLP-1R activation to cell
survival via a cAMP and PKA-dependent pathway. Furthermore,
it is possible that activation of related GPCRs also coupled to in-
duction of cAMP in b cells may produce similar effects on the
UPR. For example, we also demonstrated that GIP receptor ac-
tivation mimics the actions of exendin-4 on INS-1 cells treated
with thapsigargin, leading to reduction of eIF2a phosphorylation
and overinduction of ATF-4 and CHOP expression.
The diabetic b cell is required to chronically sustain a high
level of proinsulin production while maintaining the molecular
machinery required for accurate processing and subsequent re-
lease of mature insulin. Genetic mutations that impair ER func-
tion in the b cell lead to either accumulation of proinsulin in the
ER (Yoshioka et al., 1997), defective upregulation of insulin bio-
synthesis in the face of rising glucose (Scheuner et al., 2005), or
failure of translational attenuation (Harding et al., 2000b, 2001)
and ultimately progressive b cell dysfunction, hyperglycemia,
and apoptosis. Intriguingly, GLP-1R agonists increase first-
phase insulin release and reduce the proinsulin:insulin ratio in
diabetic subjects (Buse et al., 2004; Degn et al., 2004), indirect
evidence for acute GLP-1R-dependent restoration of a more
physiological secretory and processing pathway in islet b cells.
Furthermore, our findings using isolated rat b cells or INS-1 cells
demonstrate that exendin-4 directly relieves translational re-
pression and increases insulin biosynthesis in the setting of
ER stress via potentiation of the eIF2a phosphatase complex.
These findings may explain in part the GLP-1R-dependent res-
toration of b cell function observed in subjects with type 2 diabe-
tes (Degn et al., 2004; Rachman et al., 1996; Zander et al., 2002).
Remarkably, there is little current evidence linking GPCRabsence or presence of exendin-4 or forskolin. (A and B) Thirty minutes before harvesting, cells were labeled with [3H]leucine, and the incorporation of the tracer into 10%
trichloroacetic acid precipitable protein was assessed by scintillation counting. Data are means 6 SD of triplicate cultures and are representative of four (A) and two (B)
similar experiments. SD for data with coefficients of variation%4% is not visible on the graphs. (C and D) Whole-cell extracts were analyzed by immunoblotting for ATF-4,
P(Ser51)-eIF2a, and PP1c and in parallel subjected to microcystin affinity chromatography to purify PP1c-interacting proteins. Microcystin-agarose pull downs were im-
munoblotted with the indicated antibodies. The asterisk in (C) marks the position of an unidentified protein crossreacting with the anti-ATF-4 antibody. Results are repre-
sentative of two independent experiments.399
A R T I C L EFigure 5. Exendin-4 stimulates ER stress-induced ATF-4 translation in INS-1 cells
(A) Cellswere treatedwithvehiclealone (V)or thapsigargin (T) in theabsenceorpresenceofexendin-4 (Ex-4orE)or forskolin (FkorF) for the indicatedperiodsof time.TotalRNA
was then isolated and subjected to northern blot analysis. Blots were hybridized sequentially with radiolabeled ATF-4 and GAPDH (loading control) cDNA probes. The radio-
active signal associatedwithATF-4was quantifiedby autoradiography on a storage phosphor screen, corrected by the signal from the loading control, and expressed relative
to the values at time zero. Data are means6 SEM from three to four independent experiments. SEM for data with coefficients of variation%4% is not visible on the graph.400 CELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressactivation to alleviation of ER stress. Our data suggest that cou-
pling of GLP-1R signaling pathways to modulation of the ER
stress response represents a feasible therapeutic strategy for si-
multaneous enhancement of b cell function and insulin biosyn-
thesis while reducing the risk of cytotoxicity traditionally associ-
ated with sustained upregulation of ER function as a result of
chronic demand for protein biosynthesis.
Experimental procedures
Materials
RPMI 1640 andDMEM tissue culturemedia were fromHyClone, and fetal bo-
vine serum (FBS) and antibiotics were from Invitrogen-GIBCO. Thapsigargin,
tunicamycin, forskolin, phorbol 12-myristate 13-acetate (PMA), long R3IGF-
1, cycloheximide, actinomycin D, 5,6-dichloro-1-b-ribofuranosyl benzimid-
azole (DRB), protease inhibitor mixture (P-2714), and phosphatase inhibitor
mixture I were purchased from Sigma. GLP-1(7–36)amide, exendin-4, and
[D-Ala2]GIP were from California Peptide Research Inc. H89, PD98059,
U0126, wortmannin, and LY294002were obtained fromCalbiochem. The ex-
pression vector pCMV-FlagVASP and the reporter plasmid TK-ATF4UTR-
Luc were gifts from M.D. Uhler (University of Michigan, Ann Arbor, Michigan)
and D. Ron (Skirball Institute of Biomolecular Medicine, New York, New
York), respectively.
Animal studies
Four-week-old female db/db (BKS.Cg-m+/+Leprdb/J) mice were purchased
from Jackson Laboratories and were maintained on a 12 hr light/dark cycle
with free access to standard rodent chow and water. All animal experiments
were carried out in accordance with protocols and guidelines approved by
the Toronto General Hospital Animal Care Committee. Commencing at 4
weeks of age, when all mice were normoglycemic, they were given twice-
daily intraperitoneal (i.p.) injections of exendin-4 (24 nmol/kg) or phos-
phate-buffered saline (PBS) for 3 weeks and then sacrificed. Immediately
prior to sacrifice, blood glucose levels were measured from a tail vein sample
using a Glucometer Elite (Bayer). Pancreas samples were obtained for RNA
extraction and immunohistochemistry. For pancreatic CHOP and insulin im-
munohistochemistry, the tissue was fixed in 4% paraformaldehyde and em-
bedded in paraffin. Serial sections were stained with anti-CHOP/GADD153
(sc-575, Santa Cruz Biotechnology) or with anti-insulin (Dako Diagnostics)
antibodies using standard protocols. The insulin immunopositive area was
measured using a Leica DMR microscope equipped with a Leica DC 300F
camera and the Leica QWin V3 software (Leica Microsystems Canada
Inc.), and the number of cells exhibiting both nuclear CHOP and cytoplasmic
insulin immunopositivity was determined.
Culture of purified rat b cells and rodent insulinoma cells, drug
treatments, transient transfections, and luciferase assay
Purified b cells from adult Wistar rats were prepared as previously described
(Pipeleers et al., 1985a). Freshly isolated b cells were reaggregated for 2 hr in
a rotary shaking incubator (Pipeleers et al., 1985b) or seeded on polylysine-CELL METABOLISM : NOVEMBER 2006coated microtiter plates (Pipeleers and Van de Winkel, 1986) for studies in-
volving metabolic labeling or apoptosis assessment, respectively. Prior to
use in experiments, purified b cells were precultured for 16 hr in Ham’s F10
medium (Invitrogen-GIBCO) supplemented with 2 mM glutamine, 6.1 mM
glucose, 0.5% (w/v) charcoal extracted bovine serum albumin, 100 U/ml
penicillin, and 100 mg/ml streptomycin. Rat INS-1(832/13) cells (Hohmeier
et al., 2000) were maintained in RPMI 1640 medium supplemented with
10% heat-inactivated FBS, 100 U/ml penicillin, 100 mg/ml streptomycin, 10
mM HEPES, 4 mM glutamine, 1 mM sodium pyruvate, and 50 mM b-mercap-
toethanol. The mouse insulinoma MIN6 cell line (Miyazaki et al., 1990) was
grown in DMEM supplemented with 15% heat-inactivated FBS, 100 U/ml
penicillin, 100 mg/ml streptomycin, 4 mM glutamine, and 50 mM b-mercap-
toethanol. Except where indicated, drug treatments were performed in reg-
ular growth medium. Exendin-4, GLP-1, [D-Ala2]GIP, and IGF-1 were dis-
solved in PBS and thapsigargin, tunicamycin, forskolin, PMA, kinase
inhibitors, actinomycin D, DRB and cycloheximide in dimethyl sulfoxide. Final
concentrations of drug solvent (vehicle) were identical in every culture irre-
spective of the particular treatment group. INS-1 cells were transfected using
FuGene (Roche) or Lipofectamine 2000 (Invitrogen-GIBCO) and utilized for
experiments 24 hr later. Luciferase assays were performed as previously
described (Koehler et al., 2005).
Western blot analysis
Following drug treatment as indicated, cells were washed in ice-cold PBS
and lysed in RIPA buffer (1% Nonidet P-40, 0.5% sodium deoxycholate,
and 0.1% SDS in PBS) supplemented with protease and phosphatase inhib-
itor mixtures (both at 1:100 dilution), 10 mg/ml pepstatin A, 5mM sodium fluo-
ride, and 500 mM sodium orthovanadate. Cell lysates were cleared by centri-
fugation and boiled for 5 min in sample buffer containing b-mercaptoethanol.
Protein concentration was determined using the BCA protein assay (Pierce).
Forty to fifty micrograms of cell lysate protein was resolved by SDS-PAGE
and immunoblotted as described (Koehler et al., 2005). The following primary
antibodies were used: rabbit polyclonal antibodies to ATF-4 (sc-200), XBP-1
(sc-7160), GADD34 (sc-825) and CHOP (sc-575) (Santa Cruz Biotechnology)
at 1:500 dilutions; rabbit polyclonal antibodies reactive to phospho-eIF2a
Ser51, phospho-PERK Thr980, Akt, phospho-Akt Ser473, phospho-VASP
Ser157, Erk1/2 mitogen-activated protein kinase, and phospho-Erk1/2
Thr202/Tyr204 (Cell Signaling Technologies) at 1:1000 dilutions; and anti-
PP1c antibody (Upstate Cell Signaling Solutions) at 1:2000 dilution and
mouse monoclonal anti-Hsp90 (BD Biosciences, Mississauga, Ontario) at
1:3000 dilution. Densitometry was performed on blots exposed to Biomax
MR film (Eastman Kodak Co.) using a Hewlett-Packard ScanJet 5300C scan-
ner and NIH Image software.
Microcystin affinity chromatography
Cells were lysed in a buffer containing 137 mM NaCl, 20 mM Tris (pH 7.6),
0.25% Nonidet P-40, 5 mM NaF, 500 mM sodium orthovanadate, and prote-
ase inhibitor mixture (1:100 dilution). Lysates were cleared by centrifugation
and their protein concentration determined. Four hundredmicrograms of cell
lysate protein was incubated at 4C for 4 hr with microcystin-agarose (Up-
state Cell Signaling Solutions). Beads were then washed four times with(B) Cells were exposed to 0.5 mM thapsigargin (Tg) in the absence or presence of 50 nMexendin-4 or 20 mM forskolin for 4 hr. Cycloheximide (CHX) 80 mMwas then added to
the cultures and the incubationcontinued for the indicated periods of time. Total cell extractswere analyzedby immunoblotting for ATF-4,CHOP, andHsp90. The intensity of
the ATF-4 signal was quantified by densitometry, corrected by the loading control, and expressed relative to the values at time zero. Data are average of two independent
experiments. ATF-4 half-life was calculated from the logarithmically transformed best-fit line by linear regression analysis. Similar results were obtained when the rate of
ATF-4 decay was examined following a 1 hr treatment with thapsigargin with or without exendin-4 or forskolin (data not shown).
(C) Twenty-four hr after transfectionwith the reporter plasmid TK-ATF4UTR-Luc, cells were exposed to vehicle alone (Veh) or thapsigargin (Tg) in the absence or presence of
exendin-4 or forskolin for 4 and 8 hr. Duplicate cultures from each treatment group were used to determine luciferase activity (top) and in parallel ATF-4-luciferase mRNA
(ATF-4-Luc) expression (bottom). Luciferase activity is expressed relative to the activity of cells treatedwith vehicle alone for 4 hr following normalization for protein content.
Data aremeans6SDof quadruplicate cultures and are representative of five similar experiments. Levels of ATF-4-Luc transcriptswere assessedbynorthernblot analysis of
total RNA isolated from cells treated as indicated for 8 hr. Blots were hybridized with a radiolabeled luciferase cDNA probe. Ethidium bromide staining of the northern blot is
shown as a control for loading and integrity of RNA. Results are representative of two independent experiments.
(D) Cultures were treated with vehicle alone or 0.5 mM thapsigargin in the absence or presence of 50 nM exendin-4 for 45 min prior to and during a 15 min metabolic pulse
labeling with [35S]methionine/cysteine. Whole-cell lysates were subjected to immunoprecipitation (IP) with an ATF-4-specific antibody, and the immune complexes were
resolved by SDS-PAGE, transferred onto nitrocellulose, and revealed by autoradiography on a storage phosphor screen (top panel). An equal amount of the total cell lysates
from the same groups of radiolabeled cells was also fractionated by SDS-PAGE followed by immunoblotting with anti-ATF-4 and anti-P(Ser51)-eIF2a antibodies (middle
panels) and lastly autoradiography (bottom panel) to quantify global protein synthesis rates. An unidentified protein (asterisk) crossreacting with the anti-ATF-4 antibody
is shown to document equal loading. Molecular mass standards (in kDa) appear on the right. Results are representative of four independent experiments.401
A R T I C L EFigure 6. GLP-1R signaling enhances INS-1 survival following an ER stress challenge
Cells were pretreated with 0.2 mM thapsigargin (Tg) in the absence or presence of exendin-4 (Ex-4), GLP-1, or forskolin (Fk) for 8 hr. Drugs were then removed and the cells
allowed to resume growth in normal media for 5 days (A and B) or for up to 7 days (C). Photomicrographs illustrated in (A) were taken under phase contrast following crystal
violet staining of the cultures. Magnification, 503. Cell number was assessed at the indicated time points by using a tetrazolium salt bioreduction assay and expressed402 CELL METABOLISM : NOVEMBER 2006
Incretin hormones modulate ER stressice-cold lysis buffer and boiled in reducing sample buffer prior to SDS-PAGE
and blotting as described above.
Metabolic labeling of newly synthesized proteins
and immunoprecipitation
Tomeasure insulin synthesis in purified rat b cells, cultures were labeled for 1
hr in Ham’s F10 medium with 0.5% BSA and 250 mCi/ml of L-[3,5-3H]tyrosine
(40–60 Ci/mmol, Amersham) followed by immunoprecipitation of 3H-labeled
proteins with anti-insulin serum as previously described (Schuit et al., 1991).
To evaluate general translation rates in INS-1 cells, cultures were labeled in
normal growth medium for 30 min with 4–5 mCi/ml of L-[4,5-3H]leucine (153
Ci/mmol) (Amersham Biosciences). The cells were harvested in 1 M NaOH,
and the protein was precipitated with trichloroacetic acid (10% final concen-
tration) and recovered by centrifugation. The radioactivity associated with
the pellet wasmeasured by scintillation counting. Protein content of the pellet
was determined using the Bio-Rad Protein Assay (Bio-Rad). To assess ATF-4
synthesis in INS-1 cells, the regular culturemediumwas replaced bymedium
containing 10%of the normal methionine and cysteine content 15min before
the addition of [35S]Met/Cys EasyTag Express protein labeling mix (Perki-
nElmer Life Sciences) at 200 mCi/ml for 15 min. Cells were lysed in 0.5 M
NaCl-containing RIPA buffer and the lysate cleared by centrifugation, diluted
to 0.3 M NaCl, and subjected to immunoprecipitation with a polyclonal rabbit
anti-ATF-4 antiserum (either sc-200 from Santa Cruz Biotechnology or ob-
tained fromD. Ron) prebound to protein A agarose (Pierce). Radiolabeled im-
mune complexes were resolved by SDS-PAGE, electrotransferred to nitro-
cellulose, and revealed by autoradiography on a storage phosphor screen.
Radioactive signal quantification was performed using a Storm imaging sys-
tem and the ImageQuant software (GE Healthcare).
RNA isolation, northern blot analysis, and quantitative
real-time RT-PCR
Total RNA from pancreas samples or from INS-1 cells was extracted by the
guanidinium thiocyanate method (Chomczynski and Sacchi, 1987). For
northern blotting, 5 mg of RNA was electrophoresed in a 1% agarose-formal-
dehyde gel, transferred to a Nytranmembrane (Schleicher & Schuell), and UV
crosslinked. Blot hybridization with [32P]-radiolabeled cDNA probes was per-
formed in ExpressHyb buffer (BDBiosciences) as recommended by theman-
ufacturer. Template DNA for the probes was generated by RT-PCR (GAPDH;
see Yusta et al. [2000]) for primer sequences) or was excised from IMAGE
consortium cDNA clones purchased from the American Type Culture Collec-
tion (ATF-4, IMAGE:4992862; c-FOS, IMAGE:3688670). Luciferase template
DNA was excised from the TK-ATF4UTR-Luc reporter plasmid. After exten-
sive washing, blots were subjected to autoradiography on a storage phos-
phor screen. Quantification of the transcript levels was performed as indi-
cated above. First-strand cDNA synthesis was performed with 5 mg of
DNase I-treated total RNA using random hexamers and SuperScript II (Invi-
trogen-GIBCO) according to the manufacturer’s instructions. Duplicate ali-
quots of the first-strand reactions were used as templates for real-time quan-
titative PCR using TaqMan Gene Expression Assays and TaqMan Universal
PCR Master Mix (Applied Biosystems) on an ABI PRISM 7900HT Sequence
Detection System. Relative quantification of transcript levels was performed
by the 22DCt method (Livak and Schmittgen, 2001) using the Ct values
obtained from the PCR amplification kinetics with the ABI PRISM SDS 2.1
software.
Measurement of XBP-1 mRNA splicing
cDNA generated from total RNA as described above was used as template
for PCR with primers flanking the intron excised by IRE1 from the XBP-1CELL METABOLISM : NOVEMBER 2006mRNA. Primer sequences used to amplify rat XBP-1 were 50-AAACAGAG
TAGCAGCACAGACTGC-30 and 50-TCCTTCTGGGTAGACCTCTGGGAG-30.
The sequence of the primers utilized to amplify mouse XBP-1 has been pre-
viously reported (Iwawaki et al., 2004). Amplification was performed at an an-
nealing temperature of 60–63C for 30 cycles. PCR products were separated
by electrophoresis on a 3% agarose gel and visualized by ethidium bromide
staining. Unspliced rat XBP-1 gave a product of 480 bp, and the spliced rat
cDNA was 454 bp. Unspliced mouse XBP-1 gave a product of 205 bp, and
the spliced mouse cDNA was 179 bp. The percentage of sXBP-1 to total
XBP-1 mRNA was determined by densitometry using NIH Image software
on images of the ethidium bromide-stained gels acquired with a gel docu-
mentation system.
Quantification of apoptosis in purified rat b cell cultures
Living and dead b cells were visualized by fluorescencemicroscopy following
propidium iodide and HOECHST 3342 staining (Hoorens et al., 1996). Viable
cells were identified by their intact nuclei with blue fluorescence, necrotic
cells by their intact nuclei with yellow-red fluorescence, and apoptotic cells
by their fragmented nuclei with either blue (early apoptosis) or yellow-red
(late apoptosis) fluorescence (Hoorens et al., 1996). The apoptotic index is
defined by the following equation: (% apoptosis in drug-treated cultures 2
% apoptosis in vehicle-treated cultures)/(100 2 % apoptosis in vehicle-
treated cultures) 3 100.
Cell survival assays and colony outgrowth assessment in INS-1 cells
Cells were exposed to thapsigargin in the presence or absence of the spec-
ified agonists and/or inhibitors for 8 hr. At the indicated periods of time follow-
ing treatment, the number of viable cells in each condition was evaluated by
measuring the bioreduction of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-
thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt at 490 nm using the Cell-
Titer 96 aqueous assay (Promega). Crystal violet staining was used to reveal
cell colony outgrowth 5 days after the thapsigargin challenge. Phase contrast
images of representative areas of the stained cultures were acquired with
a Leica DC 300F camera mounted on a Leica DMIRB inverted microscope
and the Leica IM500 software.
Statistical analysis
Statistical significance was assessed by one-way analysis of variance
(ANOVA) followed by the Bonferroni multiple comparison posthoc test by
using GraphPad Prism 3.03 (GraphPad Software Inc.).
Supplemental data
Supplemental data include seven figures and Supplemental references and
can be found with this article online at http://www.cellmetabolism.org/cgi/
content/full/4/5/391/DC1/.
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termined at the indicated time points as described above. 100 refers to the cell number at the beginning of the treatments. Data (means 6 SD of quadruplicate determi-
nations) are representative of three similar experiments. (E–G) Cultures were exposed to vehicle alone, PD98059 (PD), or U0126 (U0) (E), wortmannin (W) or LY294002 (LY)
(F), or H89 (G) for 20 min prior to and during an 8 hr treatment with 0.2 mM thapsigargin in the absence or presence of exendin-4 or forskolin. Seven days after the thap-
sigargin challenge, cell number was determined and expressed relative to the cell number in the cultures treated with thapsigargin alone. Data shown in (E) and (F) are
means6 SD of representative experiments performed in quadruplicate and repeated twice. Data shown in (G) are means6 SE (n = 4 independent experiments each per-
formed in quadruplicate). Statistical comparisons are relative to the corresponding cultures treated by thapsigargin alone (*p < 0.05, ***p < 0.001).403
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